A randomized placebo-controlled trial of desipramine, cognitive behavioral therapy, and active placebo therapy for low back pain

Pain

Volumn 161, Issue 6, 2020, Pages 1341-1349

  Gould, Hilary M ^a,b   Atkinson, Joseph Hampton ^a,b   Chircop Rollick, Tatiana ^b   D'Andrea, John ^a,b   Garfin, Steven ^b   Patel, Shetal M ^a   Funk, Stephen D ^a   Capparelli, Edmund V ^b   Penzien, Donald B ^c   Wallace, Mark ^b   Weickgenanta, Anne L ^e   Slater, Mark ^d   Rutledge, Thomas ^a,b  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d Virginia G Piper Cancer Center   (United States)

^e NONE

Author keywords

Antidepressant; Chronic back pain; Cognitive behavioral therapy; Randomized controlled trial

Indexed keywords

DESIPRAMINE;

BACKACHE; CHRONIC PAIN; COGNITIVE BEHAVIORAL THERAPY; CONTROLLED STUDY; HUMAN; LOW BACK PAIN; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

BACK PAIN; CHRONIC PAIN; COGNITIVE BEHAVIORAL THERAPY; DESIPRAMINE; HUMANS; LOW BACK PAIN; TREATMENT OUTCOME;

EID: 85084927313     PISSN: 03043959     EISSN: 18726623     Source Type: Journal    
DOI: 10.1097/j.pain.0000000000001834     Document Type: Article

References (36)

1. Atkinson JH, Slater MA, Capparelli EV, Wallace MS, Zisook S, Abramson I, Matthews SC, Garfin SR. Efficacy of noradrenergic and serotonergic antidepressants in chronic back pain. J Clin Psychopharmacol 2007;27: 135-42.
2. Basler HD, Jakle C, Kroner-Herwig B. Incorporation of cognitivebehavioral treatment into the medical care of chronic low back patients. Patient Educ Couns 1997;31:113-24.
3. Castelnuovo G, Giusti E, Manzoni GM, Saviola D, Gabrielli S, Lacerenza M, Pietrabissa G, Cattivelli R, Spatola CAM, Rossi A, Varallo G, Novelli M, Villa V, Luzzati F, Cottini A, Lai C, Volpato E, Cavalera C, Pagnini F, Tesio V, Castelli L, Tavola M, Torta R, Arreghini M, Zanini L, Brunani A, Seitanidis I, Ventura G, Capodaglio P, D'Aniello GE, Scarpina F, Brioschi A, Bigoni M, Priano L, Mauro A, Riva G, Di Lernia D, Repetto C, Regalia C, Molinari E, Notaro P, Paolucci S, Sandrini G, Simpson S, Wiederhold BK, Gaudio S, Jackson JB, Tamburin S, Benedetti F. What is the role of the placebo effect for pain relief in neurorehabilitation? Clinical implications from the Italian Consensus Conference on Pain in Neurorehabilitation. Front Neurol 2018;9:310.
4. Chou R, Ballantyne JC, Fanciullo GJ, Fine PG, Miaskowski C. Research gaps on use of opioids for chronic noncancer pain: findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain 2009;10:147-59.
5. Chou R, Deyo R, Friedly J, Skelly A, Weimer M, Fu R, Dana T, Kraegel P, Griffin J, Grusing S. Systemic pharmacologic therapies for low back pain: a systematic review for an American College of Physicians clinical practice guideline. Ann Intern Med 2017;166:480-92.
6. Chou R, Huffman LH. Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians Clinical Practice Guideline. Ann Intern Med 2007;147: 505-14.
7. Dunn KM, Saunders KW, Rutter CM, Banta-Green CJ, Merrill JO, Sullivan MD, Weisner CM, Silverberg MJ, Campbell CI, Psaty BM, Von Korff M. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med 2010;152:85-92.
8. Dworkin RH, Turk DC, Farrar JT, Haythornthwaite J, Jensen M, Katz N, Kerns R, Stucki G, Allen R, Bellamy N. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. PAIN 2005;113:9-19.
9. Ehde DM, Dillworth TM, Turner JA. Cognitive-behavioral therapy for individuals with chronic pain: efficacy, innovations and directions for research. Amer Psychol 2014;69:153-66.
10. Fillingim RB, Loeser JD, Baron R, Edwards RR. Assessment of chronic pain: domains, methods, and mechanisms. J Pain 2016;17(9 suppl): T10-20.
11. First MB, Spitzer RL, Gibbon M, William JBW. Structured clinical interview for DSM-IV axis I disorders, clinician version (SCID-CV). Washington, DC: American Psychiatric Press, Inc, 1996.
12. Flor H, Fydrich T, Turk DC. Efficacy of multidisciplinary pain treatment centers: a meta-analytic review. PAIN 1992;49:221-30.
13. Gracely RH, Kwilosz DM. The Descriptor Differential Scale: applying psychophysical principles to clinical pain assessment. PAIN 1988;35: 279-88.
14. Guzmán J, Esmail R, Karjalainen K, Malmivaara A, Irvin E, Bombardier C. Multidisciplinary rehabilitation for chronic low back pain: systematic review. BMJ 2001;322:1511-16.
15. Haythornthwaite JA. Clinical trials studying pharmacotherapy and psychological treatments alone and together. Neurol 2005;65(12 suppl 4):S20-31.
16. Hicks J, Sangkuhl KK, Swen JJ, Ellingrod VL, Müller DJ, Shimoda K, Bishop JR, Kharasch ED, Skaar TC, Gaedigk A, Dunnenberger HM, Klein TE, Caudle KE, Stingl JC. Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update. Clin Pharmacol Ther 2017;102:37-44.
17. Hoffman BM, Papas RK, Chatkoff DK, Kerns RD. Meta-analysis of psychological interventions for chronic low back pain. Health Psychol 2007;26:1-9.
18. Holroyd KA, O'Donnell FJ, Stensland M, Lipchik GL, Cordingley GE, Carlson BW. Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination. JAMA 2001;285:2208-15.
19. Institute of Medicine (US) Committee on Advancing Pain Research, Care, and Education. Relieving pain in America: a blueprint for transforming prevention, care, education, and research. Washington, DC: National Academies Press (US), 2011. 3, Care of People with Pain.
20. Kamper SJ, Apeldoorn AT, Chiarotto A, Smeets RJ, Ostelo RW, Guzman J, van Tulder MW. Multidisciplinary biopsychosocial rehabilitation for chronic low back pain: cochrane systematic review and meta-analysis. BMJ 2015;350:h444.
21. Kaptchuk TJ, Miller FG. Placebo effects in medicine. N Engl J Med 2015; 373:8-9.
22. Lingjaerde O. UKU side effect rating scale. Acta Psychiat Scand 1987;76: 7-96.
23. Manchikanti L, Abdi S, Atluri S, Balog CC, Benyamin RM, Boswell MV, Brown KR, Bruel BM, Bryce DA, Burks PA, Burton AW, Calodney AK, Caraway DL, Cash KA, Christo PJ, Damron KS, Datta S, Deer TR, Diwan S, Eriator I, Falco FJ, Fellows B, Geffert S, Gharibo CG, Glaser SE, Grider JS, Hameed H, Hameed M, Hansen H, Harned ME, Hayek SM, Helm S II, Hirsch JA, Janata JW, Kaye AD, Kaye AM, Kloth DS, Koyyalagunta D, Lee M, Malla Y, Manchikanti KN, McManus CD, Pampati V, Parr AT, Pasupuleti R, Patel VB, Sehgal N, Silverman SM, Singh V, Smith HS, Snook LT, Solanki DR, Tracy DH, Vallejo R, Wargo BW. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part I-evidence assessment. Pain Physician 2012;15(3 suppl):S1-65.
24. McGrew JH, Bond GR, Dietzen L, Salyers M. Measuring the fidelity of implementation of a mental health program model. J Consult Clin Psych 1994;62:670-8.
25. Ostelo RW, Deyo RA, Stratford P, Waddell G, Croft P, Von Korff M, Bouter LM, de Vet HC. Interpreting change scores for pain and functional status in low back pain: towards international consensus regarding minimal important change. Spine 2008;33:90-4.
26. Roland M, Morris R. A study of the natural history of back pain. Part I: development of a reliable and sensitive measure of disability in low-back pain. Spine 1983;8:141-4.
27. Salerno SM, Browning R, Jackson JL. The effect of antidepressant treatment on chronic back pain: a meta-analysis. Arch Intern Med 2002; 162:19-24.
28. Spina E, Gitto C, Avenoso A, Campo GM, Caputi AP, Perucca E. Relationship between plasma desipramine levels, CYP2D6 phenotype and clinical response to desipramine: a prospective study. Eur J Clin Pharmacol 1997;51:395.
29. Spitzer WO, LeBlanc FE, Dupuis M, Gore DR, Murray MP, Gardner GM, Sepic SB. Scientific approach to the assessment and management of activity-related spinal disorders. A monograph for clinicians. Report of the Quebec Task Force on Spinal Disorders. Spine 1987;12:4-59.
30. Staiger TO, Gaster B, Sullivan MD, Deyo RA. Systematic review of antidepressants in the treatment of chronic low back pain. Spine 2003; 28:2540-5.
31. Turk DC. Cognitive-behavioral approach to the treatment of chronic pain patients. Reg Anesth Pain Med 2003;28:573-9.
32. Turner JA, Deyo RA, Loeser JD, VonKorff M, Fordyce WE. The importance of placebo effects in pain treatment and research. JAMA 1994;20:1609-14.
33. Urquhart DM, Hoving JL, Assendelft WJJ, Roland M, van Tulder MW. Antidepressants for non-specific low back pain. Cochrane Database Syst Rev 2008;1:CD001703.
34. US Natl Inst Health. Current medication information for benztropine mesylate, 2007. Available at: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid53d2732f9-b8a9-4e83-91e7-da616ddcb786. Accessed August 2009.
35. Williams AC, Eccleston C, Morley S. Psychological therapies for the management of chronic pain (excluding headache) in adults. Cochrane Database Syst Rev 2012;11:CD007407.
36. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2163-96.